Cargando…

Long term follow-up of children with juvenile systemic sclerosis, mixed connective tissue disease and pulmonary disease

Detalles Bibliográficos
Autores principales:	Dracou, C, Syridou, G, Drakonaki, S, Grigoriadou, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334036/ http://dx.doi.org/10.1186/1546-0096-6-S1-P231

Ejemplares similares

Exercise limitation in juvenile onset Mixed Connective Tissue Disease (MCTD)
por: Net, JJ van der, et al.
Publicado: (2008)

Interstial granulomatous dermatitis as initial presentation of juvenile mixed connective disease and its response to tacrolimus
por: Jung, Lawrence, et al.
Publicado: (2012)

Treatment for pulmonary manifestations of juvenile systemic sclerosis
por: Henstorf, Gretchen, et al.
Publicado: (2012)

Collaboration in long term follow-up of juvenile idiopathic arthritis
por: Larbre, JP, et al.
Publicado: (2008)

Tocilizumab for the treatment of refractory pediatric mixed connective tissue disease (MCTD), in two patients
por: Cabrera, Natalia, et al.
Publicado: (2014)

The prospective juvenile systemic sclerosis inceptions cohort – http://www.juvenile-scleroderma.com
por: Foeldvari, I, et al.
Publicado: (2008)

Subcutaneous Mycobacterium avium complex infection in an adolescent with mixed connective tissue disease receiving mycophenolate mofetil
por: Isgro, Josephine, et al.
Publicado: (2012)

The juvenile systemic sclerosis clinic: an interdisciplinary approach
por: Katsicas, Marìa, et al.
Publicado: (2012)

Juvenile systemic sclerosis: review of 15 patients
por: Sousa, Sandra I, et al.
Publicado: (2014)

Update on the juvenile systemic sclerosis inception cohort http://www.juvenile-scleroderma.com
por: Foeldvari, Ivan, et al.
Publicado: (2014)

Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease
por: Niklas, Karolina, et al.
Publicado: (2018)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

The frequency of pulmonary hypertension in juvenile scleroderma
por: Adrovic, Amra, et al.
Publicado: (2014)

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs
por: Consolaro, A, et al.
Publicado: (2013)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis
por: Culpo, Roberta, et al.
Publicado: (2014)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
por: Consolaro, A, et al.
Publicado: (2008)

The analysis of specific antinuclear antibodies concentrations in children with connective tissue diseases
por: Klochkova, Olga, et al.
Publicado: (2011)

Gastrointestinal involvement in juvenile systemic sclerosis: development of recommendations for screening and investigation
por: Pain, Clare, et al.
Publicado: (2014)

Cardiopulmonary involvement in juvenile systemic sclerosis: development of recommendations for screening and investigation
por: Pain, Clare, et al.
Publicado: (2014)

PReS-FINAL-2016: Bone mineral status in a long-term follow up of juvenile dermatomyositis patients
por: Kristensen, VA, et al.
Publicado: (2013)

Manifestation of connective tissue diseases (CTD) in pediatrics patients with autoimmune hepatitis (AIH)
por: Garay, S, et al.
Publicado: (2011)

Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients
por: Aikawa, Nadia E, et al.
Publicado: (2012)

PReS-FINAL-2163: Disease activity in a juvenile idiopathic arthritis population after 5 years follow-up
por: Marques, R, et al.
Publicado: (2013)

Non-HLA genepolymorphisms in juvenile chronic arthritis: associations with outcome of disease
por: Alberdi-Saugstrup, Mikel, et al.
Publicado: (2014)

Coeliac disease and intestinal inflammation in juvenil idiopathic arthritis
por: Nuñez, Esmeralda, et al.
Publicado: (2011)

PReS-FINAL-2172: Efficacy of corticosteroids and intravenous cyclophosphamide for patients with juvenile systemic sclerosis
por: Kikuchi, M, et al.
Publicado: (2013)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
por: Schiappapietra, B, et al.
Publicado: (2011)

Juvenile dermatomyositis is a different disease in children up to three years of age at onset than in children above three years at onset
por: Patwardhan, Anjali, et al.
Publicado: (2012)

Juvenile chronic non-bacterial osteomyelitis (CNO): Long term course of disease and response to treatment in a large institutional cohort
por: Schwarz, T, et al.
Publicado: (2015)

PReS-FINAL-2267: Successful treatment of pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD) with combination therapy of sildenafil and ambrisentan: a case report
por: Yamaguchi, KI, et al.
Publicado: (2013)

Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis
por: Cantarini, L, et al.
Publicado: (2011)

8.3 Disease patterns in Danish Juvenile Dermatomyositis patients
por: Mathiesen, PR, et al.
Publicado: (2008)

Disease patterns in juvenile dermatomyositis patients from Mumbai, India
por: Khubchandani, RP, et al.
Publicado: (2011)

Prevalence and pattern of total and partial anomalous pulmonary venous connection in Indian patients with congenital heart disease
por: Raj, Vimal, et al.
Publicado: (2015)

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis
por: Consolaro, A, et al.
Publicado: (2011)

PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis
por: Lavric, M, et al.
Publicado: (2013)

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
por: Rossi, L, et al.
Publicado: (2008)

The clinical course and long-term outcome of juvenile systemic lupus erythematosus
por: Wierzbowska, M, et al.
Publicado: (2008)

Long term follow-up after sudden withdrawal from a multicentric study of abatacept in juvenile idiopathic arthritis – data from the Portuguese cohort
por: Gomes, S Melo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5lb8vgep05a91pnbpbrrv0269l